PSC
Piper Sandler & Co Portfolio holdings
AUM
$130M
This Quarter Return
-1.76%
1 Year Return
-0.04%
3 Year Return
-0.42%
5 Year Return
-3.12%
10 Year Return
–
AUM
$20.6M
AUM Growth
+$20.6M
(-18%)
Cap. Flow
-$2.01M
Cap. Flow
% of AUM
-9.78%
Top 10 Holdings %
Top 10 Hldgs %
99.95%
Holding
41
New
11
Increased
–
Reduced
2
Closed
14
Top Buys
| 1 |
SAAS
inContact, Inc.
SAAS
|
$284K |
| 2 |
Gilead Sciences
GILD
|
$165K |
| 3 |
Protolabs
PRLB
|
$84K |
| 4 |
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
|
$24K |
| 5 |
KSU
Kansas City Southern
KSU
|
$17K |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$759K |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$481K |
| 3 |
vTv Therapeutics
VTVT
|
$360K |
| 4 |
Bausch Health
BHC
|
$201K |
| 5 |
Tenet Healthcare
THC
|
$180K |
Sector Composition
| 1 | Healthcare | 16.61% |
| 2 | Technology | 1.41% |
| 3 | Industrials | 0.49% |
| 4 | Consumer Discretionary | 0% |
| 5 | Financials | 0% |
